ERBA Molecular

ERBA Molecular

ERBA Molecular is a successful and innovative molecular IVD company applying its commercially validated proprietary technology in sample preparation, amplification and detection to produce novel workflow based solutions to reduce the complexity of molecular testing. ERBA Molecular was created by the acquistion of Lumora Ltd in September 2015 by ERBA Mannheim GmbH.

Telephone: +44 (0)1353 667 907
Address: Unit 4 Bartholomew's Walk, Cambridgeshire Business Park, Ely
Postcode: CB7 4EA
Country: United Kingdom
Website: http://www.erbamdx.co.uk/
Membership type:Corporate 6-20 (£250+VAT pa)

ERBA MDX has successfully condensed complex molecular diagnostic technologies into a few simple steps requiring a minimally skilled operator and consequently the potential for a CLIA waivable POC system for use in a wide range of decentralized testing environments, including resource-poor settings in clinical diagnostics and industrial microbiology.

Erba Molecular makes a quality decision

Erba Molecular continues the expansion of its team with the appointment of Dr Sarah Mardle as Director of Quality & Operations.

5 December 2016Read in full

Lumora sells Heat Elution technology to Roche

Lumora, a provider of state-of-the-art molecular diagnostic products for the clinical research and industrial markets, has sold its proprietary nucleic acid Heat Elution purification technology to Roche.

26 August 2015Read in full

Patent published for Lumora’s novel sample preparation technology

Lumora, a provider of state-of-the-art molecular diagnostic products for the clinical and industrial market, has received a patent for its Heat Elution Sample Preparation technology, which has the potential to help commercial laboratories simplify the process and save valuable time and money in sample preparation.

8 November 2013Read in full

Lumora signs supply agreement with Promega for Ultra-Glo luciferase

Lumora, a provider of state-of-the-art molecular diagnostic products for the clinical and industrial market, and Promega, a leader in providing innovative solutions and technical support to the life sciences industry, have signed a supply agreement for the use of Promega’s Ultra-Glo™ luciferase in Lumora’s BART (Bioluminescent Assay in Real-Time) molecular diagnostics technology.

29 July 2013Read in full